Patients: Intraperitoneal chemotherapy ‘worth it’ for ovarian cancer

WASHINGTON – Intraperitoneal chemotherapy may be unpleasant and interfere with daily life, but the large majority of women who received it for ovarian cancer agreed that it was the right choice for...
Source: Family Practice News - Category: Primary Care Source Type: news